Baird Medical Investment Holdings (BDMD) Non-Current Deferred Tax Liability (2024 - 2025)
Baird Medical Investment Holdings' (BDMD) quarterly Non-Current Deferred Tax Liability came in at $21559.0 in Q2 2025, down 52.34% on a QoQ basis from $45238.0 in Q4 2024.
Baird Medical Investment Holdings (BDMD) Non-Current Deferred Tax Liability (2024 - 2025) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $21559.0 in Q2 2025.
- On a quarterly basis, Non-Current Deferred Tax Liability changed N/A year-over-year to $21559.0 in Q2 2025; TTM through Jun 2025 was $21559.0, a N/A change from a year earlier, with the FY2024 full-year figure at $45238.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability for Q2 2025 stood at $21559.0, down from $45238.0 in the prior quarter.
- Over the last five years, Non-Current Deferred Tax Liability for BDMD reached as high as $45238.0 in Q4 2024 and fell as low as $21559.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Baird Medical Investment Holdings | 30.57 Mn | 30.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 21,559.00 |
| Jun 30, 2025 | 21,559.00 |
| Dec 31, 2024 | 45,238.00 |
| Dec 31, 2024 | 45,238.00 |